Photo taken from mountsinai.org
Jul 28, 2024, 09:39
Jess Scott: What is the optimal exercise dose in prostate cancer?
Oncologists shared about new trial in JAMA Oncology:
Jess Scott, Exercise oncology researcher at MSK Cancer Center, shared on X:
“What is the optimal exercise dose in prostate cancer? Team MSK Cancer Center used a digitized, decentralized platform to test 90-450 mins/wk and found ALL doses were feasible, but 225-375 mins/wk associated with tumor activity.
This was a phase 1a nonrandomized trial to identify recommended phase 2 dose (RP2D). All study procedures/training conducted remotely in patients’ homes. Based on feasibility-tumor activity ratio, 225 mins/wk selected as RP2D”
Neoadjuvant Exercise Therapy in Prostate CancerA Phase 1, Decentralized Nonrandomized Controlled Trial
Autors:
Neil Iyengar, Oncologist at at Memorial Sloan Kettering, shared on X:
“New in JAMA Oncology: in this first of its kind phase 1 dose finding trial, 225 min/week of mod-intensity treadmill walking was identified as the recommended phase 2 dose in men with prostate cancer. Therapeutic dose range of exercise also PSA and Ki-67.”
Source: Jess Scott/X and Neil Iyengar/X
Anne Collins
Behfar Ehdaie
cancer
Catherine P. Lee
Chau T. Dang
Chaya S. Moskowitz
Gina A. Fickera
Irina Linkov
James A. Eastham
Jess Scott
Jessica A. Lavery
Kurtis Stoeckel
Lee W. Jones
Lydia Y. Liu
Meghan G. Michalski
MSK Cancer Center
OncoDaily
Oncology
Patricia T. Sheerin
Paul C. Boutros
prostate cancer
Stefan E. Eng
Su S. Chun
tumor activity
Umeshkumar Bhanot
Vincent P. Laudone
Whitney P. Underwood
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43
Nov 12, 2024, 19:34